Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Treatment of Gastric MALT Lymphoma
NCT00002682Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 1995
- Primary completion
- Oct 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of amoxicillin, clarithromycin, tetracycline, metronidazole, omeprazole and 1 more in gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Number of Patients with Response to Antibiotic Treatment of Gastric Malt Lymphoma at 3 years. Started Aug 1995; status: completed.
02
Drugs
amoxicillinclarithromycintetracyclinemetronidazoleomeprazole
03
Conditions
gastric mucosa-associated lymphoid tissue lymphomaHelicobacter pylori infection
Beyond the preview
Go deeper on NCT00002682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002682.